Dent Neurologic

new masking policy – masks are now optional

DENTNeuro_White

Fran M. Gengo

PharmD

Dr. Gengo serves as Director of Neuropharmacology and the Research Director for the Acute Stroke Treatment Program at DENT, as well as the the Chief Science Officer for DENT’s research affiliate, DNRC. Dr. Gengo is also the Neuropharmacological Director for the DENT Cannabis Clinic.

 

Dr. Gengo is located at DENT Tower in Amherst.

He is currently involved in several protocols of thrombolytics and neuroprotective agents. In addition, he is an Associate Professor of Pharmacy and Neurology and a Clinical Assistant Professor of Neurosurgery at the SUNY at Buffalo School of Medicine.

Dr. Gengo has published numerous papers on the effects of various drugs on the central nervous system and his research entails abstraction and statistical analysis of data acquired from several modalities.

SPECIALITIES

- Neurology
- Neuropharmacology
- Pharmacotherapy

Board Certifications​

- 2005 Neurology
- 2011 Neuroimaging
- 2016 Neurology

Publications

See publications for Fran M. Gengo, PharmD

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with DENT Neurologic Institute)

Titles

- Director of Neuropharmacology
- Research Director, DENT Acute Stroke Treatment Program
- Chief Science Officer, DENT’s research affiliate, DNRC.
- Neuropharmacological Director, DENT Cannabis Clinic.
- Associate Professor of Pharmacy and Neurology, SUNY at Buffalo School of Medicine
- Clinical Assistant Professor of Neurosurgery, SUNY at Buffalo School of Medicine.

Education

Medical / Graduate Education
Philadelphia College of Pharmacy and Science, Philadelphia, PA

Fellowship
SUNY at Buffalo, Department of Pharmaceutics, Buffalo, NY – Pharmacokinetics and Biopharmaceutics

Open Clinical Trials

  • All
  • ALS
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • NP
  • Parkisons Disease
  • Physician assistant
  • Provider
  • Research Study
  • service
  • Treatment-Resistant Depression
Epilepsy

STARS and STARS Extension

Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Read More →
Alzheimer's

RETHINK-ALZ

Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease

Read More →
Dizziness and Balance

Hearing Study

Hearing Study | FX-322 Can a single dose medication potentially restore lost hearing? We’re working to find out. FX-322 is a new investigational drug that …

Read More →
Epilepsy

X-TOLE: XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open-Label Extension

A clinical research study is underway for people with focal epilepsy currently taking 1-3 anti-epileptic drugs that are still experiencing frequent seizures. Three doses of investigational drug are being studied and some participants will be assigned placebo. All participants will receive active study on the extension study.

Read More →
Dizziness and Balance

Meniere’s Disease

Meniere’s Disease Have you been diagnosed with Meniere’s disease? If so, you may be eligible for a clinical trial. This trial is being conducted to …

Read More →
Alzheimer's

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects

PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects Inclusion Criteria Age 55-90 years Have a reliable study partner, …

Read More →
Alzheimer's

Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)

The Alzheimer’s Disease Neuroimaging Initiative (also known as ADNI) is a historic study of brain aging looking to help change the future for this disease.

Read More →
Headache/Migraine

CGBG Study

We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a period of up to five weeks.

Read More →

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Call us to schedule an appointment

Our entire team, from customer service to patient providers, is focused on the central mission to deliver superior clinical care, advanced neurodiagnostics, clinical research and education that will assist our patients in maximizing their quality of life. We strive to exceed the expectations of our patients, clinical partnerships and community partners.

Scroll to Top